132 related articles for article (PubMed ID: 12014733)
1. Molecular alterations in chronic ulcerative colitis-associated and sporadic hyperplastic polyps: a comparative analysis.
Odze RD; Brien T; Brown CA; Hartman CJ; Wellman A; Fogt F
Am J Gastroenterol; 2002 May; 97(5):1235-42. PubMed ID: 12014733
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations in chronic ulcerative colitis-associated adenoma-like DALMs are similar to non-colitic sporadic adenomas.
Odze RD; Brown CA; Hartmann CJ; Noffsinger AE; Fogt F
Am J Surg Pathol; 2000 Sep; 24(9):1209-16. PubMed ID: 10976694
[TBL] [Abstract][Full Text] [Related]
3. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis.
Chaubert P; Benhattar J; Saraga E; Costa J
Am J Pathol; 1994 Apr; 144(4):767-75. PubMed ID: 8160776
[TBL] [Abstract][Full Text] [Related]
4. Hyperplastic polyp with epithelial misplacement (inverted hyperplastic polyp): a clinicopathologic and immunohistochemical study of 19 cases.
Yantiss RK; Goldman H; Odze RD
Mod Pathol; 2001 Sep; 14(9):869-75. PubMed ID: 11557782
[TBL] [Abstract][Full Text] [Related]
5. Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological, and molecular review.
Odze RD
Am J Gastroenterol; 1999 Jul; 94(7):1746-50. PubMed ID: 10406230
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in serrated adenomas: comparison to conventional adenomas and hyperplastic polyps.
Fogt F; Brien T; Brown CA; Hartmann CJ; Zimmerman RL; Odze RD
Hum Pathol; 2002 Jan; 33(1):87-91. PubMed ID: 11823977
[TBL] [Abstract][Full Text] [Related]
7. P53 and beta catenin expression in chronic ulcerative colitis--associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study.
Walsh SV; Loda M; Torres CM; Antonioli D; Odze RD
Am J Surg Pathol; 1999 Aug; 23(8):963-9. PubMed ID: 10435567
[TBL] [Abstract][Full Text] [Related]
8. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
Fujii S; Fujimori T; Chiba T
J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
[TBL] [Abstract][Full Text] [Related]
10. A high degree of aneuploidy, loss of p53 gene, and low soluble p53 protein serum levels are detected in ulcerative colitis patients.
Rosman-Urbach M; Niv Y; Birk Y; Smirnoff P; Zusman I; Morgenstern S; Schwartz B
Dis Colon Rectum; 2004 Mar; 47(3):304-13. PubMed ID: 14991492
[TBL] [Abstract][Full Text] [Related]
11. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms.
Tarmin L; Yin J; Harpaz N; Kozam M; Noordzij J; Antonio LB; Jiang HY; Chan O; Cymes K; Meltzer SJ
Cancer Res; 1995 May; 55(10):2035-8. PubMed ID: 7743497
[TBL] [Abstract][Full Text] [Related]
12. Sporadic adenomas in chronic ulcerative colitis.
Fogt F
Z Gastroenterol; 2003 Apr; 41(4):343-6. PubMed ID: 12695941
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability and K-ras mutations in patients with ulcerative colitis.
Lyda MH; Noffsinger A; Belli J; Fenoglio-Preiser CM
Hum Pathol; 2000 Jun; 31(6):665-71. PubMed ID: 10872658
[TBL] [Abstract][Full Text] [Related]
14. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Nagai M; Watanabe M; Iwase T; Yamao K; Isaji S
World J Surg; 2002 Jan; 26(1):91-8. PubMed ID: 11898040
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutations of the first 14 exons of APC in hamartomatous polyps of the colon.
Kim JC; Roh SA; Kim HC; Yu CS; Lee DH; Ahn BY; Kim KM; Yang SK; Kang GH; Beck NE; Bodmer WF
Hum Mutat; 1999 Oct; 14(4):351-2. PubMed ID: 10502830
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential?
Morimoto LM; Newcomb PA; Ulrich CM; Bostick RM; Lais CJ; Potter JD
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1012-8. PubMed ID: 12376501
[TBL] [Abstract][Full Text] [Related]
17. [Molecular carcinogenesis in ulcerative colitis-associated and sporadic colorectal carcinoma--differences and similarities].
Aust DE; Baretton GB; Waldman FM; Löhrs U
Verh Dtsch Ges Pathol; 1999; 83():130-8. PubMed ID: 10714203
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).
de vos tot Nederveen Cappel WH; Offerhaus GJ; van Puijenbroek M; Caspers E; Gruis NA; De Snoo FA; Lamers CB; Griffioen G; Bergman W; Vasen HF; Morreau H
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3598-605. PubMed ID: 14506146
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions.
Parwani AV; Geradts J; Caspers E; Offerhaus GJ; Yeo CJ; Cameron JL; Klimstra DS; Maitra A; Hruban RH; Argani P
Mod Pathol; 2003 Apr; 16(4):299-308. PubMed ID: 12692194
[TBL] [Abstract][Full Text] [Related]
20. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis.
Engelsgjerd M; Farraye FA; Odze RD
Gastroenterology; 1999 Dec; 117(6):1288-94; discussion 1488-91. PubMed ID: 10579969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
